Seminal plasma induces programmed cell death in cultured peripheral blood mononuclear cells

AIDS Research and Human Retroviruses

Volumn 18, Issue 11, 2002, Pages 797-803

  Okamoto, Mari ^a,b   Byrn, Randall ^c   Eyre, Robert C ^a   Mullen, Tom ^a   Church, Paul ^a   Kiessling, Ann A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Rehabilitation Center   (Japan)

^c VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; DNA FRAGMENT; FLUORESCENT DYE; PHYTOHEMAGGLUTININ; PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL LOSS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONONUCLEAR CELL; NICK END LABELING; NORMAL HUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REGULATORY MECHANISM; SAMPLING; SEMINAL PLASMA; SEMINAL VESICLE; VASECTOMY;

APOPTOSIS; CELLS, CULTURED; HUMANS; IN SITU NICK-END LABELING; LEUKOCYTES, MONONUCLEAR; MALE; SEMEN;

EID: 0036346551     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220260139549     Document Type: Article

References (40)

1. Suppressive effect of seminal plasma on lymphocyte activation
2. Immunosuppression by seminal plasma and its possible clinical significance
3. Immunosuppressive mechanisms in semen: Implications for contraception
4. Regulation of the proinflammatory effects of Fas ligand (CD95L)
5. A role for CD95 ligand in preventing graft rejection
6. Immunosuppression by human seminal plasma fractionated by DEAE Sephadex A-50 ion exchange chromatography
7. Human immunodeficiency virus in semen
8. The use of serum-free medium delays, but does not prevent, the cytotoxic effects of seminal plasma in lymphocyte cultures: Implications for studies on HIV infection
9. Detection of human immunodeficiency virus in cell-free seminal fluid
10. HIV-1 in semen: An isolated virus reservoir
11. Analysis of human immunodeficiency virus in semen: Indications of a genetically distinct virus reservoir
12. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood
13. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission
14. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors
15. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir
16. Human immunodeficiency virus load. Quantitative assessment in semen from seropositive individuals and in spiked seminal plasma
17. Sensitive method for the detection of infectious HIV in semen of seropositive individuals
18. Effect of prostatic fluid and its fractions on some functions of peritoneal macrophages
19. Relative immunosuppressive activity of human seminal prostaglandins
20. Isolation of two novel E prostaglandins in human seminal fluid
21. The effects of human seminal plasma and PGE2 on mitogen induced proliferation and cytokine production of human splenic lymphocytes and peripheral blood mononuclear cells
22. Role of spermine in the cytotoxic effects of seminal plasma
23. Methods for detecting apoptotic cell in tissues
24. Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-κB and AP-1 transcription factors
25. Human immunodeficiency virus detection and differential leukocyte counts are accurate and safer with formaldehyde-fixed blood
26. Interaction of gametes with exogenous genes: Possible opportunities for incorporation into embryonic genome
27. In vitro studies in reproductive immunology. 1. Suppression of cell-mediated immune response by human spermatozoa and fractions isolated from human seminal plasma
28. Effect of seminal plasma and its fractions on in vitro blastogenic response to mitogen
29. The effect of seminal plasma on macrophage function - A possible contributory factor in sexually transmitted disease
30. The identification of factors in seminal plasma responsible for suppression of natural killer cell activity
31. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells
32. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group
33. The transmission of AIDS: The case of the infected cells
34. Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma
35. Multiple drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy
36. Human seminal plasma from vasectomised individuals is immunosuppressive
37. Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells
38. Perplexing problem of persistently painful prostatitis
39. Cancer statistics, 1998